BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26339563)

  • 21. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T; Yazici Y; Bergman MJ
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.
    Salaffi F; Ciapetti A; Gasparini S; Carotti M; Bombardieri S;
    Clin Exp Rheumatol; 2012; 30(6):912-21. PubMed ID: 22935335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience.
    Abdulaziz S; Almaqati AS; Komo K; Alahmadi A
    Cureus; 2023 Sep; 15(9):e44982. PubMed ID: 37822428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Remotely Applied and Face-to-Face Disease Activity Scores in Saudi Arabian Patients With Rheumatoid Arthritis: A Prospective Cohort Study.
    Almansouri AY; Alsofyani R; Alharbi HA; Almaqati AS; Aloqbi HS; Bakhsh L; Althubaiti A; Alzahrani Z
    Cureus; 2024 Jan; 16(1):e52390. PubMed ID: 38361704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAPID3 scores and hand outcome measurements in RA patients: a preliminary study.
    Qorolli M; Hundozi-Hysenaj H; Rexhepi S; Rehxepi B; Grazio S
    Clin Rheumatol; 2017 Jun; 36(6):1379-1385. PubMed ID: 28028685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of the Virtual Monitoring Clinic, a novel nurse-led service for monitoring patients with stable rheumatoid arthritis.
    Chew LC; Xin X; Yang H; Thumboo J
    Int J Rheum Dis; 2019 Apr; 22(4):619-625. PubMed ID: 30450812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
    Lee SW; Kim SY; Chang SH
    BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
    Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
    Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-cultural and clinical validation of the MDHAQ/RAPID3 questionnaire in electronic format for a Brazilian population of patients with rheumatoid arthritis.
    Lineburger IB; Brenol CV; Goularte AS; Pinheiro EP; Hirakata VN
    Adv Rheumatol; 2022 Nov; 62(1):46. PubMed ID: 36419141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.
    Walker UA; Mueller RB; Jaeger VK; Theiler R; Forster A; Dufner P; Ganz F; Kyburz D
    Rheumatology (Oxford); 2017 Oct; 56(10):1707-1712. PubMed ID: 28957553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pragmatic and scientific advantages of MDHAQ/ RAPID3 completion by all patients at all visits in routine clinical care.
    Pincus T; Yazici Y; Castrejón I
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():30-6. PubMed ID: 23259656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Barriers to treatment optimization and achievement of patients' goals: perspectives from people living with rheumatoid arthritis enrolled in the ArthritisPower registry.
    Gavigan K; Nowell WB; Serna MS; Stark JL; Yassine M; Curtis JR
    Arthritis Res Ther; 2020 Jan; 22(1):4. PubMed ID: 31910893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of patient-reported outcomes in the assessment of rheumatoid arthritis disease activity:the experience of the ESPOIR cohort.
    Che H; Combe B; Morel J; Cantagrel A; Gossec L; Lukas C
    Clin Exp Rheumatol; 2016; 34(4):646-54. PubMed ID: 27384748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Proposal to Standardize Low Disease Activity Criteria in Rheumatoid Arthritis Based on the Outcome Measures in Rheumatology Minimal Disease Activity Definition.
    Yokogawa N; Shimada K; Sugii S; Komiya A; Matsui T; Nishino J; Tohma S
    ACR Open Rheumatol; 2020 May; 2(5):301-306. PubMed ID: 32362072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis.
    Cinar M; Yilmaz S; Cinar FI; Koca SS; Erdem H; Pay S; Dinc A; Yazici Y; Simsek I
    Rheumatol Int; 2015 Sep; 35(9):1575-80. PubMed ID: 25794571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAPID3? Aptly named!
    Berthelot JM
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-80-4. PubMed ID: 25365094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the derived 28-joint disease activity score patient-reported components (DAS28-P) index as a discriminatory measure of response to disease-modifying anti-rheumatic drug therapy in early rheumatoid arthritis.
    Pisaniello HL; Whittle SL; Lester S; Menz F; Metcalf R; McWilliams L; Hill CL; Proudman S
    BMC Rheumatol; 2022 Nov; 6(1):67. PubMed ID: 36376988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites.
    El-Haddad C; Castrejon I; Gibson KA; Yazici Y; Bergman MJ; Pincus T
    RMD Open; 2017; 3(1):e000391. PubMed ID: 29225915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.